Highlights and Quick Summary
- Net Profit Margin for the quarter ending September 30, 2022 was -693.56% (a 60.52% increase compared to previous quarter)
- Year-over-year quarterly Net Profit Margin increased by 447.36%
- Annual Net Profit Margin for 2021 was -714.91% (a -99.91% decrease from previous year)
- Annual Net Profit Margin for 2020 was -816120.83% (a 61.36% increase from previous year)
- Annual Net Profit Margin for 2019 was -505777.78% (a -Infinity% decrease from previous year)
- Twelve month Net Profit Margin ending September 30, 2022 was -343.06% (a 12.77% increase compared to previous quarter)
- Twelve month trailing Net Profit Margin decreased by -52.01% year-over-year
Trailing Net Profit Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -343.06% | -304.21% | -395.37% | -714.91% |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Profit Margin of Beam Therapeutics Inc.
Most recent Net Profit Marginof BEAM including historical data for past 10 years.Interactive Chart of Net Profit Margin of Beam Therapeutics Inc.
Beam Therapeutics Inc. Net Profit Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | -693.56% | -432.08% | -820.85% | – |
| 2021 | -126.71% | -3685.19% | -1270883.33% | -3359333.33% | -714.91% |
| 2020 | -1591066.67% | -574200.0% | -570300.0% | -528916.67% | -816120.83% |
| 2019 | -464166.67% | -371116.67% | -351450.0% | 0.0% | -505777.78% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology